PMC:7377212 / 1562-1782 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T33","span":{"begin":4,"end":27},"obj":"UBERON:0001558"},{"id":"T34","span":{"begin":28,"end":33},"obj":"NCBITaxon:10239"},{"id":"T35","span":{"begin":106,"end":114},"obj":"SP_7"},{"id":"T36","span":{"begin":124,"end":137},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T37","span":{"begin":172,"end":178},"obj":"NCBITaxon:4751"},{"id":"T38","span":{"begin":207,"end":215},"obj":"SP_7"},{"id":"T48068","span":{"begin":4,"end":27},"obj":"UBERON:0001558"},{"id":"T57817","span":{"begin":28,"end":33},"obj":"NCBITaxon:10239"},{"id":"T8958","span":{"begin":106,"end":114},"obj":"SP_7"},{"id":"T86360","span":{"begin":124,"end":137},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T64802","span":{"begin":172,"end":178},"obj":"NCBITaxon:4751"},{"id":"T86299","span":{"begin":207,"end":215},"obj":"SP_7"}],"text":" of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 asso"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":4,"end":27},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma45662"}],"text":" of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 asso"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":4,"end":27},"obj":"Body_part"},{"id":"T5","span":{"begin":10,"end":27},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":" of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 asso"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T34","span":{"begin":28,"end":43},"obj":"Disease"},{"id":"T35","span":{"begin":34,"end":43},"obj":"Disease"},{"id":"T36","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"T37","span":{"begin":182,"end":191},"obj":"Disease"},{"id":"T38","span":{"begin":207,"end":215},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 asso"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":4,"end":27},"obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"T15","span":{"begin":58,"end":59},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 asso"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":124,"end":137},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":" of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 asso"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":28,"end":43},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":" of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 asso"}